Protein Engineering Market Analysis - North America, Europe, Asia, Rest of World (ROW) - US, UK, Germany, China, Japan - Size and Forecast 2023-2027

Published: Oct 2023 Pages: 161 SKU: IRTNTR76259

Protein Engineering Market Forecast 2023-2027

The protein engineering market size is forecast to increase by USD 2.38 billion between 2022 and 2027, accelerating at a CAGR of 15.42%. In 2017, the US held the largest market share, projecting an annual revenue of USD 353.73 million. The convergence of various cutting-edge technologies, including artificial intelligence (AI), computational biology, and structural analysis, has paved the way for the creation of integrated tools offering comprehensive solutions to overcome environmental challenges in protein engineering.

What will be the Size of the Protein Engineering Market During the Forecast Period?

To learn more about this report, Download Report Sample

Market Segmentation

The instruments segment is the Leading Segment to Dominate the Market

The instruments segment was valued at USD 649.40 million in 2017. Within the instruments segment, a diverse range of instruments is utilized. These include high-performance liquid chromatography (HPLC) systems, mass spectrometers, nuclear magnetic resonance (NMR) spectrometers, protein crystallization platforms, and automated protein expression systems.The instruments segment facilitates protein engineering by accelerating processes that were previously time- and labor-intensive. The growing demand for biopharmaceuticals, including monoclonal antibodies, enzymes, and therapeutic proteins, has driven the need for advanced tools to facilitate the detection, optimization, and production of these complex molecules. The convergence of various technologies, such as AI, computational biology, and structural analysis, has led to the creation of integrated tools that provide comprehensive solutions to overcome environmental challenges. Thus, such factors will drive the growth of the segment during the forecast period. 

Market  - Revenue Share by Instruments Segment, 2017 - 2027.   

For more details on other segments, Download Sample Report 

North America Holds a Prominent Position in the Market

North America is estimated to contribute 38% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers will shape the market during the forecast period. The market in North America is heavily focused on biopharmaceutical applications. The development of new therapeutic proteins, including monoclonal antibodies, enzymes, and cytokines, is a driving force in North America, supported by the region's expertise in drug discovery and development biology.

Furthermore, the North American region is home to many leading pharmaceutical companies, biotech companies, and research institutes that are at the forefront of advances. North America has always been at the forefront of technological innovation related to protein engineering. North America is at the forefront of advances in computational modeling, structural biology engineering, and AI-based approaches that enable rapid protein design, optimization, and characterization. Collaborations between academia, industry, and research institutions are common in North America. Hence, such factors are expected to drive market growth in this region during the forecast period. 

Market Size, By Region, Global, 2017 - 2027.   

To understand geographic trends Download Report Sample

Market Dynamics and Customer Landscape

The market is witnessing significant growth driven by advancements in biotechnology and pharmaceutical research, with notable contributions from institutions like Eindhoven University of Technology. This market is fueled by the increasing prevalence of chronic diseases, spurring the development of targeted therapies and precision medicine approaches, particularly in cancer treatment. The emergence of AI-designed proteins and bioluminescent testing kits is revolutionizing the field, enabling researchers to generate biomedicines with enhanced efficacy. Monoclonal antibodies, insulin, and other protein-based therapies are gaining traction, offering promising outcomes for patients with cancer and autoimmune diseases. Synthetic biology plays a pivotal role in the production of these protein-based drugs, augmenting the capabilities of biotechnology and pharmaceutical businesses. As the market continues to evolve, stakeholders are closely monitoring buying behavior, patient outcomes, and the adoption of protein engineering solutions in diagnostics and therapeutics.

In the food industry, consumer preference for healthier and more sustainable food choices has driven demand for new proteins with improved nutritional profiles. It allows the development of proteins with optimized amino acid compositions, improved digestibility, and reduced allergenicity. Furthermore, it plays a central role in industrial processes. Enzymes, which are specialized proteins, are widely used as biological catalysts in various industrial applications. By designing enzymes with greater activity, stability, and specificity, end-user industries such as biofuels and detergents can realize more efficient production processes more efficient and more environmentally friendly.  Hence, these factors are expected to fuel the growth of the global market share during the forecast period.

Protein Engineering Market Companies Overview

The Protein Engineering Market is fragmented in nature. Some significant players include Agilent Technologies Inc., Amgen Inc., Bio Rad Laboratories Inc., Bruker Corp., Danaher Corp., Eli Lilly and Co., General Electric Co.

The research report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:

GenScript Biotech Corp., Merck KGaA, New England Biolabs Inc., Novo Nordisk AS, PerkinElmer Inc., Promega Corp., Thermo Fisher Scientific Inc., and Waters Corp.

Segment Overview

The market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 - 2027.   

  • Product Outlook 
    • Instruments
    • Reagents
  • End-User Outlook 
    • Pharmaceutical and biotechnology companies
    • Contract research organizations
    • Academic research institutes
  • Region Outlook 
    • North America
      • The U.S.
      • Canada
    • Europe
      • The U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • Rest of the World (ROW)
      • Brazil 
      • Argentina
      • Australia

Market Analyst Overview

The Market is witnessing remarkable growth driven by advancements in biotechnology and pharmaceutical businesses. With a focus on precision medicine and personalized therapies, protein-based therapies are becoming increasingly vital in treating chronic diseases like cancer, autoimmune diseases, and cardiovascular conditions. Innovations in AI-designed proteins and rational protein design are revolutionizing the field, enabling the generation of biomedicines tailored to individual patient needs. Private and public investments fuel research and development spending, leading to the development of targeted therapies and personalized diagnostics. Key stakeholders, including Ginkgo Bioworks and Centers for Disease Control and Prevention (CDC), play crucial roles in shaping the market landscape. With a focus on improving patient outcomes and addressing chronic and lifestyle disorders, the Protein Engineering Market continues to thrive, supported by ongoing advancements in synthetic biology and enzyme R&D.

Moreover, the market is experiencing remarkable growth driven by advancements in biomedicines and the increasing prevalence of chronic and lifestyle disorders like diabetes and cardiovascular issues. Bioluminescent diagnostic kits are revolutionizing cancer treatment and diagnosis, particularly in breast cancer detection, aided by the insights provided by Canadian Cancer Statistics. Protein therapeutics, including insulin and erythropoietin, play crucial roles in addressing protein deficiency disorders and immune system modulation. With a focus on R&D spending, companies are developing innovative protein-based vaccines and non-protein drugs, catering to diverse medical needs. Ginkgo Enzyme Services and manufacturing processes are integral to protein type development, ensuring product and service quality. The market's growth is also fueled by investments in cardiovascular repair and addressing coagulation and colony-stimulating factors, showcasing changing buying behaviors towards protein-based treatments.

Additionally, the Market is experiencing significant growth driven by advancements in biomedicines and the increasing prevalence of chronic and lifestyle disorders. Protein engineering techniques enable the development of innovative bioluminescent diagnostic kits and testing kits, catering to diverse healthcare needs. Moreover, the market benefits from the rising demand for coagulation factors and interferons, essential in treating various medical conditions. Conference and webinar materials facilitate knowledge exchange and drive research in protein engineering, supported by funds allocated for biomedicine research. Host strains play a crucial role in biomedicine production, ensuring product and service quality. Protein engineering addresses critical healthcare challenges such as Protein-Energy Malnutrition (PEM), offering promising solutions to improve patient outcomes and combat disease. With the continuous evolution of protein engineering technologies, the market is poised for sustained growth and innovation.

Protein Engineering Market Scope

Report Coverage

Details

Page number

161

Base year

2022

Historic period

2017 - 2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 15.42%

Market growth 2023-2027

USD 2.38 billion

Market structure

Fragmented

YoY growth 2022-2023(%)

14.29

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 38%

Key countries

US, UK, Germany, China, and Japan

Competitive landscape

 Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

Key companies profiled

Agilent Technologies Inc., Amgen Inc., Bio Rad Laboratories Inc., Bruker Corp., Danaher Corp., Eli Lilly and Co., General Electric Co., GenScript Biotech Corp., Merck KGaA, New England Biolabs Inc., Novo Nordisk AS, PerkinElmer Inc., Promega Corp., Thermo Fisher Scientific Inc., and Waters Corp.

Market dynamics

Parent market analysis, Market forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View PDF Sample

What are the Key Data Covered in this Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the market growth and forecasting of the market between 2023 and 2027
  • Precise estimation of the size of the market size and its contribution to the parent market
  • Accurate predictions about upcoming market trends and analysis and changes in consumer behavior
  • Growth of the market industry across Europe, North America, APAC, South America, and Middle East and Africa
  • Thorough market growth analysis of the market’s competitive landscape and detailed information about vendors
  • Comprehensive market analysis and report on the factors that will challenge the market research and growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. 

Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Global protein engineering market 2017 - 2021
      • Exhibit 18: Historic Market Size – Data Table on global protein engineering market 2017 - 2021 ($ million)
    • 4.2 Product Segment Analysis 2017 - 2021
      • Exhibit 19: Historic Market Size – Product Segment 2017 - 2021 ($ million)
    • 4.3 End-User Segment Analysis 2017 - 2021
      • Exhibit 20: Historic Market Size – End-User Segment 2017 - 2021 ($ million)
    • 4.4 Geography Segment Analysis 2017 - 2021
      • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
    • 4.5 Country Segment Analysis 2017 - 2021
      • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by Product

    • 6.1 Market segments
      • Exhibit 30: Chart on Product - Market share 2022-2027 (%)
      • Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
    • 6.2 Comparison by Product
      • Exhibit 32: Chart on Comparison by Product
      • Exhibit 33: Data Table on Comparison by Product
    • 6.3 Instruments - Market size and forecast 2022-2027
      • Exhibit 34: Chart on Instruments - Market size and forecast 2022-2027 ($ million)
      • Exhibit 35: Data Table on Instruments - Market size and forecast 2022-2027 ($ million)
      • Exhibit 36: Chart on Instruments - Year-over-year growth 2022-2027 (%)
      • Exhibit 37: Data Table on Instruments - Year-over-year growth 2022-2027 (%)
    • 6.4 Reagents - Market size and forecast 2022-2027
      • Exhibit 38: Chart on Reagents - Market size and forecast 2022-2027 ($ million)
      • Exhibit 39: Data Table on Reagents - Market size and forecast 2022-2027 ($ million)
      • Exhibit 40: Chart on Reagents - Year-over-year growth 2022-2027 (%)
      • Exhibit 41: Data Table on Reagents - Year-over-year growth 2022-2027 (%)
    • 6.5 Market opportunity by Product
      • Exhibit 42: Market opportunity by Product ($ million)
      • Exhibit 43: Data Table on Market opportunity by Product ($ million)

    7 Market Segmentation by End-user

    • 7.1 Market segments
      • Exhibit 44: Chart on End-user - Market share 2022-2027 (%)
      • Exhibit 45: Data Table on End-user - Market share 2022-2027 (%)
    • 7.2 Comparison by End-user
      • Exhibit 46: Chart on Comparison by End-user
      • Exhibit 47: Data Table on Comparison by End-user
    • 7.3 Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027
      • Exhibit 48: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
      • Exhibit 49: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
      • Exhibit 50: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
      • Exhibit 51: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
    • 7.4 Contract research organizations - Market size and forecast 2022-2027
      • Exhibit 52: Chart on Contract research organizations - Market size and forecast 2022-2027 ($ million)
      • Exhibit 53: Data Table on Contract research organizations - Market size and forecast 2022-2027 ($ million)
      • Exhibit 54: Chart on Contract research organizations - Year-over-year growth 2022-2027 (%)
      • Exhibit 55: Data Table on Contract research organizations - Year-over-year growth 2022-2027 (%)
    • 7.5 Academic research institutes - Market size and forecast 2022-2027
      • Exhibit 56: Chart on Academic research institutes - Market size and forecast 2022-2027 ($ million)
      • Exhibit 57: Data Table on Academic research institutes - Market size and forecast 2022-2027 ($ million)
      • Exhibit 58: Chart on Academic research institutes - Year-over-year growth 2022-2027 (%)
      • Exhibit 59: Data Table on Academic research institutes - Year-over-year growth 2022-2027 (%)
    • 7.6 Market opportunity by End-user
      • Exhibit 60: Market opportunity by End-user ($ million)
      • Exhibit 61: Data Table on Market opportunity by End-user ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 63: Chart on Market share by geography 2022-2027 (%)
      • Exhibit 64: Data Table on Market share by geography 2022-2027 (%)
    • 9.2 Geographic comparison
      • Exhibit 65: Chart on Geographic comparison
      • Exhibit 66: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2022-2027
      • Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
      • Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
    • 9.4 Europe - Market size and forecast 2022-2027
      • Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • 9.5 Asia - Market size and forecast 2022-2027
      • Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
      • Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
      • Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
      • Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
    • 9.7 US - Market size and forecast 2022-2027
      • Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
      • Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
    • 9.8 UK - Market size and forecast 2022-2027
      • Exhibit 87: Chart on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 88: Data Table on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 89: Chart on UK - Year-over-year growth 2022-2027 (%)
      • Exhibit 90: Data Table on UK - Year-over-year growth 2022-2027 (%)
    • 9.9 Germany - Market size and forecast 2022-2027
      • Exhibit 91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 93: Chart on Germany - Year-over-year growth 2022-2027 (%)
      • Exhibit 94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
    • 9.10 China - Market size and forecast 2022-2027
      • Exhibit 95: Chart on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 96: Data Table on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 97: Chart on China - Year-over-year growth 2022-2027 (%)
      • Exhibit 98: Data Table on China - Year-over-year growth 2022-2027 (%)
    • 9.11 Japan - Market size and forecast 2022-2027
      • Exhibit 99: Chart on Japan - Market size and forecast 2022-2027 ($ million)
      • Exhibit 100: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
      • Exhibit 101: Chart on Japan - Year-over-year growth 2022-2027 (%)
      • Exhibit 102: Data Table on Japan - Year-over-year growth 2022-2027 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 103: Market opportunity by geography ($ million)
      • Exhibit 104: Data Tables on Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 105: Impact of drivers and challenges in 2022 and 2027
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 107: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 108: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 109: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 110: Matrix on vendor position and classification
            • 12.3 Agilent Technologies Inc.
              • Exhibit 111: Agilent Technologies Inc. - Overview
              • Exhibit 112: Agilent Technologies Inc. - Business segments
              • Exhibit 113: Agilent Technologies Inc. - Key offerings
              • Exhibit 114: Agilent Technologies Inc. - Segment focus
            • 12.4 Amgen Inc.
              • Exhibit 115: Amgen Inc. - Overview
              • Exhibit 116: Amgen Inc. - Product / Service
              • Exhibit 117: Amgen Inc. - Key offerings
            • 12.5 Bio Rad Laboratories Inc.
              • Exhibit 118: Bio Rad Laboratories Inc. - Overview
              • Exhibit 119: Bio Rad Laboratories Inc. - Business segments
              • Exhibit 120: Bio Rad Laboratories Inc. - Key news
              • Exhibit 121: Bio Rad Laboratories Inc. - Key offerings
              • Exhibit 122: Bio Rad Laboratories Inc. - Segment focus
            • 12.6 Bruker Corp.
              • Exhibit 123: Bruker Corp. - Overview
              • Exhibit 124: Bruker Corp. - Business segments
              • Exhibit 125: Bruker Corp. - Key news
              • Exhibit 126: Bruker Corp. - Key offerings
              • Exhibit 127: Bruker Corp. - Segment focus
            • 12.7 Danaher Corp.
              • Exhibit 128: Danaher Corp. - Overview
              • Exhibit 129: Danaher Corp. - Business segments
              • Exhibit 130: Danaher Corp. - Key news
              • Exhibit 131: Danaher Corp. - Key offerings
              • Exhibit 132: Danaher Corp. - Segment focus
            • 12.8 Eli Lilly and Co.
              • Exhibit 133: Eli Lilly and Co. - Overview
              • Exhibit 134: Eli Lilly and Co. - Product / Service
              • Exhibit 135: Eli Lilly and Co. - Key news
              • Exhibit 136: Eli Lilly and Co. - Key offerings
            • 12.9 General Electric Co.
              • Exhibit 137: General Electric Co. - Overview
              • Exhibit 138: General Electric Co. - Business segments
              • Exhibit 139: General Electric Co. - Key news
              • Exhibit 140: General Electric Co. - Key offerings
              • Exhibit 141: General Electric Co. - Segment focus
            • 12.10 GenScript Biotech Corp.
              • Exhibit 142: GenScript Biotech Corp. - Overview
              • Exhibit 143: GenScript Biotech Corp. - Business segments
              • Exhibit 144: GenScript Biotech Corp. - Key news
              • Exhibit 145: GenScript Biotech Corp. - Key offerings
              • Exhibit 146: GenScript Biotech Corp. - Segment focus
            • 12.11 Merck KGaA
              • Exhibit 147: Merck KGaA - Overview
              • Exhibit 148: Merck KGaA - Business segments
              • Exhibit 149: Merck KGaA - Key news
              • Exhibit 150: Merck KGaA - Key offerings
              • Exhibit 151: Merck KGaA - Segment focus
            • 12.12 New England Biolabs Inc.
              • Exhibit 152: New England Biolabs Inc. - Overview
              • Exhibit 153: New England Biolabs Inc. - Product / Service
              • Exhibit 154: New England Biolabs Inc. - Key offerings
            • 12.13 Novo Nordisk AS
              • Exhibit 155: Novo Nordisk AS - Overview
              • Exhibit 156: Novo Nordisk AS - Business segments
              • Exhibit 157: Novo Nordisk AS - Key offerings
              • Exhibit 158: Novo Nordisk AS - Segment focus
            • 12.14 PerkinElmer Inc.
              • Exhibit 159: PerkinElmer Inc. - Overview
              • Exhibit 160: PerkinElmer Inc. - Business segments
              • Exhibit 161: PerkinElmer Inc. - Key news
              • Exhibit 162: PerkinElmer Inc. - Key offerings
              • Exhibit 163: PerkinElmer Inc. - Segment focus
            • 12.15 Promega Corp.
              • Exhibit 164: Promega Corp. - Overview
              • Exhibit 165: Promega Corp. - Product / Service
              • Exhibit 166: Promega Corp. - Key offerings
            • 12.16 Thermo Fisher Scientific Inc.
              • Exhibit 167: Thermo Fisher Scientific Inc. - Overview
              • Exhibit 168: Thermo Fisher Scientific Inc. - Business segments
              • Exhibit 169: Thermo Fisher Scientific Inc. - Key news
              • Exhibit 170: Thermo Fisher Scientific Inc. - Key offerings
              • Exhibit 171: Thermo Fisher Scientific Inc. - Segment focus
            • 12.17 Waters Corp.
              • Exhibit 172: Waters Corp. - Overview
              • Exhibit 173: Waters Corp. - Business segments
              • Exhibit 174: Waters Corp. - Key news
              • Exhibit 175: Waters Corp. - Key offerings
              • Exhibit 176: Waters Corp. - Segment focus

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 177: Inclusions checklist
                • Exhibit 178: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 179: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 180: Research methodology
                • Exhibit 181: Validation techniques employed for market sizing
                • Exhibit 182: Information sources
              • 13.5 List of abbreviations
                • Exhibit 183: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              protein engineering market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis